Expression analysis across different stages of lung cancer progression using TCGA data indicated that NLN is significantly upregulated in stage I of both lung adenocarcinoma and squamous cell carcinoma, with a trend of increasing expression as the stage advances in lung adenocarcinoma (Fig. S1E and F). Here, NLN is linked to lung adenocarcinoma.